A Clinical Trial to Study the Effect of the Addition of Vitamin D to Conventional Treatment in New Pulmonary Tuberculosis Patients

NCT00366470 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Tuberculosis

Interventions

DRUG: A. 100,000 IU Cholecalciferol per dose of 3.3ml
OTHER: B. Migliol Oil without Cholecalciferol

Sponsor

Peter Daley

Collaborators

[object Object]